Efficacy and safety of Gegen Qinlian tablets in attenuating immune-related adverse events in NSCLC patients: A randomized controlled, multicenter, open-label trial in China.

Authors: Xing Yu Lu, Aolin Wang, Dongna Chen, Meng Yang, Yongming Zhang, Meng Liu, Xiaoyan Zhang, Yuan Li, Daiwei Liu, Yunliang Wang, Zhiqiang Cheng, Liya Li, Huijuan Cui

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20592

Source: Full article

---

Abstract

e20592